Bullishcharts

Bullish formation and Golden cross in Kindred Bio-sciences

Long
NASDAQ:KIN   None
Entry level $8.54 = Target price $9.55 = Stop loss $8.34
Golden cross .
Indicators all bullish .
Buy side dominance in volume .
Reaching the apex of symmetrical triangle
Company profile
Kindred Biosciences , Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
📈Daily Chart Analysis on NYSE & NASDAQ-listed Companies

⭐Free Email Newsletter > https://BullishCharts.com/

🔵Telegram Channel > https://t.me/BullishCharts

🔥YouTube > https://youtube.com/c/BullishCharts

⚡LiveChat > https://discord.gg/BullishCharts

Comments